President Trump on Friday said his administration is “very much eliminating the middlemen” who have contributed to high drug prices.
Trump’s rhetoric during his White House Rose Garden speech mirrors other criticisms from top administration officials about middlemen called pharmacy benefit managers who negotiate with drug makers on behalf of employer and union health plans. He also took aim at foreign companies that get pharmaceuticals for much less than U.S. consumers.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.